131 related articles for article (PubMed ID: 32830303)
1. Anti-Melanoma Activity of Indomethacin Incorporated into Mesoporous Silica Nanoparticles.
Ferreira NH; Ribeiro AB; Rinaldi-Neto F; Fernandes FS; do Nascimento S; Braz WR; Nassar EJ; Tavares DC
Pharm Res; 2020 Aug; 37(9):172. PubMed ID: 32830303
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Mesoporous Silica Nanoparticles for Targeted Drug Delivery Applications.
Abu-Dief AM; Alsehli M; Al-Enizi A; Nafady A
Curr Drug Deliv; 2022; 19(4):436-450. PubMed ID: 34238185
[TBL] [Abstract][Full Text] [Related]
3. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
Baeza A; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
[TBL] [Abstract][Full Text] [Related]
4. The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.
Shao D; Lu MM; Zhao YW; Zhang F; Tan YF; Zheng X; Pan Y; Xiao XA; Wang Z; Dong WF; Li J; Chen L
Acta Biomater; 2017 Feb; 49():531-540. PubMed ID: 27836804
[TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
[TBL] [Abstract][Full Text] [Related]
6. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
Kumar P; Tambe P; Paknikar KM; Gajbhiye V
Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy.
Ali OM; Bekhit AA; Khattab SN; Helmy MW; Abdel-Ghany YS; Teleb M; Elzoghby AO
Colloids Surf B Biointerfaces; 2020 Apr; 188():110824. PubMed ID: 32023511
[TBL] [Abstract][Full Text] [Related]
8. Drug encapsulation and release by mesoporous silica nanoparticles: the effect of surface functional groups.
Tan SY; Ang CY; Li P; Yap QM; Zhao Y
Chemistry; 2014 Sep; 20(36):11276-82. PubMed ID: 25044108
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of novel platinum(ii) based AIE compound-encapsulated mesoporous silica nanoparticles for cancer theranostic application.
Pasha SS; Fageria L; Climent C; Rath NP; Alemany P; Chowdhury R; Roy A; Laskar IR
Dalton Trans; 2018 Mar; 47(13):4613-4624. PubMed ID: 29517794
[TBL] [Abstract][Full Text] [Related]
10. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Giret S; Wong Chi Man M; Carcel C
Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
[TBL] [Abstract][Full Text] [Related]
11. Functionalized mesoporous silica nanoparticles in anticancer therapeutics.
Barkat A; Beg S; Panda SK; S Alharbi K; Rahman M; Ahmed FJ
Semin Cancer Biol; 2021 Feb; 69():365-375. PubMed ID: 31442571
[TBL] [Abstract][Full Text] [Related]
12. Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro.
Juneja R; Vadarevu H; Halman J; Tarannum M; Rackley L; Dobbs J; Marquez J; Chandler M; Afonin K; Vivero-Escoto JL
ACS Appl Mater Interfaces; 2020 Sep; 12(35):38873-38886. PubMed ID: 32805923
[TBL] [Abstract][Full Text] [Related]
13. Combination of 3-methyladenine therapy and Asn-Gly-Arg (NGR)-modified mesoporous silica nanoparticles loaded with temozolomide for glioma therapy in vitro.
Zhang P; Tang M; Huang Q; Zhao G; Huang N; Zhang X; Tan Y; Cheng Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):549-556. PubMed ID: 30600180
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
Goel S; Mishra P
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances.
Ghaferi M; Koohi Moftakhari Esfahani M; Raza A; Al Harthi S; Ebrahimi Shahmabadi H; Alavi SE
J Drug Target; 2021 Feb; 29(2):131-154. PubMed ID: 32815741
[TBL] [Abstract][Full Text] [Related]
17. PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy.
Choi JY; Ramasamy T; Kim SY; Kim J; Ku SK; Youn YS; Kim JR; Jeong JH; Choi HG; Yong CS; Kim JO
Acta Biomater; 2016 Jul; 39():94-105. PubMed ID: 27163403
[TBL] [Abstract][Full Text] [Related]
18. Antitumor potential of cisplatin loaded into SBA-15 mesoporous silica nanoparticles against B16F1 melanoma cells: in vitro and in vivo studies.
Drača D; Edeler D; Saoud M; Dojčinović B; Dunđerović D; Đmura G; Maksimović-Ivanić D; Mijatović S; Kaluđerović GN
J Inorg Biochem; 2021 Apr; 217():111383. PubMed ID: 33582397
[TBL] [Abstract][Full Text] [Related]
19. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
[TBL] [Abstract][Full Text] [Related]
20. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
